Artivion Inc AORT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AORT is a good fit for your portfolio.
News
-
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
-
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
-
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
-
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
Trading Information
- Previous Close Price
- $20.92
- Day Range
- $19.70–20.64
- 52-Week Range
- $12.16–21.90
- Bid/Ask
- $17.00 / $30.00
- Market Cap
- $845.46 Mil
- Volume/Avg
- 190,588 / 220,057
Key Statistics
- Price/Earnings (Normalized)
- 99.48
- Price/Sales
- 2.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.06%
Company Profile
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,500
- Website
- https://www.artivion.com
Comparables
Valuation
|
Metric
|
AORT
|
OFIX
|
LMAT
|
|---|---|---|---|
Price/Earnings (Normalized) | 99.48 | 601.44 | 47.05 |
Price/Book Value | 3.05 | 0.84 | 4.80 |
Price/Sales | 2.41 | 0.67 | 7.42 |
Price/Cash Flow | 24.34 | 60.38 | 29.91 |
Price/Earnings
AORT
OFIX
LMAT
Financial Strength
|
Metric
|
AORT
|
OFIX
|
LMAT
|
|---|---|---|---|
Quick Ratio | 2.30 | 0.98 | 4.36 |
Current Ratio | 4.85 | 2.54 | 6.51 |
Interest Coverage | 0.10 | −16.23 | — |
Quick Ratio
AORT
OFIX
LMAT
Profitability
|
Metric
|
AORT
|
OFIX
|
LMAT
|
|---|---|---|---|
Return on Assets (Normalized) | 1.09% | −13.57% | 11.05% |
Return on Equity (Normalized) | 3.01% | −19.53% | 12.77% |
Return on Invested Capital (Normalized) | 4.33% | −16.16% | 11.25% |
Return on Assets
AORT
OFIX
LMAT
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vyskdjbmm | Ftcblmd | $185.5 Bil | |
SYK
| Stryker Corp | Lmtykyxxs | Rrljy | $128.2 Bil | |
MDT
| Medtronic PLC | Dxjmdydx | Jhmrck | $106.7 Bil | |
BSX
| Boston Scientific Corp | Jssbjylw | Lxzwkdx | $99.0 Bil | |
DXCM
| DexCom Inc | Vkllbqzy | Rlxv | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Kssrxqpcx | Gqdmljx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wzrrwvzqf | Fccr | $24.9 Bil | |
ALGN
| Align Technology Inc | Lptjzxq | Lwswjtt | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Pbtwgwzf | Kzmnl | $18.9 Bil | |
PODD
| Insulet Corp | Lgkvvzmpw | Wlmsrys | $11.7 Bil |